A bioengineered arginine-depleting enzyme as a long-lasting therapeutic agent against cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A bioengineered arginine-depleting enzyme as a long-lasting therapeutic agent against cancer

Published:2020-03-06 Issue:9 Volume:104 Page:3921-3934
ISSN:0175-7598
Container-title:Applied Microbiology and Biotechnology
language:en
Short-container-title:Appl Microbiol Biotechnol

Author:

Chung Sai-Fung,Kim Chi-Fai,Tam Suet-Ying,Choi Man-Chung,So Pui-Kin,Wong Kwok-Yin,Leung Yun-Chung,Lo Wai-Hung

Funder

Hong Kong Research Grants Council (RGC) General Research Fund

Hong Kong Polytechnic University

Publisher

Springer Science and Business Media LLC

Subject

Applied Microbiology and Biotechnology,General Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s00253-020-10484-4.pdf

Reference43 articles.

1. Abou-Alfa GK, Qin S, Ryoo BY, Lu SN, Yen CJ, Feng YH, Lim HY, Izzo F, Colombo M, Sarker D, Bolondi L, Vaccaro G, Harris WP, Chen Z, Hubner RA, Meyer T, Sun W, Harding JJ, Hollywood EM, Ma J, Wan PJ, Ly M, Bomalaski J, Johnston A, Lin CC, Chao Y, Chen LT (2018) Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. Ann Oncol 29(6):1402–1408. https://doi.org/10.1093/annonc/mdy101

2. Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, Ensor CM, Prestayko AW, Holtsberg FW, Bomalaski JS, Clark MA, Savaraj N, Feun LG, Logan TF (2005) Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 23(30):7660–7668. https://doi.org/10.1200/JCO.2005.02.0933

3. Ash DE (2004) Structure and function of arginases. J Nutr 134(10):2765S–2767S. https://doi.org/10.1093/jn/134.10.2760S

4. Behi J, Hassiki R, Said NB, Bouhaouala-Zahar B, Benkhoud ML (2018) Optimization of PEGylation reaction time and molar ratio of rhG-CSF toward increasing bioactive potency of monoPEGylated protein. Int J Biol Macromol 109:888–895. https://doi.org/10.1016/j.ijbiomac.2017.11.070

5. Blick SKA, Curran MP (2007) Certolizumab pegol in Crohn's disease. Biodrugs 21(3):195–201. https://doi.org/10.2165/00063030-200721030-00006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a bioengineered Erwinia chrysanthemi asparaginase to enhance its anti-solid tumor potential for treating gastric cancer;International Journal of Biological Macromolecules;2023-12

2. Development and characterization of fused human arginase I for cancer therapy;Investigational New Drugs;2023-08-03

3. Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment;International Journal of Molecular Sciences;2023-06-26

4. Mono-PEGylated thermostable Bacillus caldovelox arginase mutant (BCA-M-PEG20) induces apoptosis, autophagy, cell cycle arrest and growth inhibition in gastric cancer cells;Investigational New Drugs;2022-07-20

5. Functionalized quinolizinium-based fluorescent reagents for modification of cysteine-containing peptides and proteins;RSC Advances;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3